MRK merck.com: שווי פעילות לרווח לפני ריבית, מסים ופחת

Production robotization and AI-driven compound analysis are increasing the profitability of Merck & Co., Inc. (MRK). The company's trend EV/EBITDA level demonstrates the current business value relative to operating income, where the 21.23 indicator expresses the state of the metric. An elite scientific staff ensures breakthroughs in vaccination, while the monopoly status of oncology drugs guarantees pricing power despite US regulatory risks.

EV/EBITDA determines the value of a business relative to its operating profit before depreciation, interest, and taxes. The metric aggregates market capitalization and net debt, allowing for an assessment of the asset's real price regardless of the financing structure. Analyzing the EV/EBITDA ratio of Merck & Co., Inc. (MRK) helps identify asset undervaluation during periods of volatility. This is critical for Merck & Co., Inc. (MRK) amid large-scale investments in environmental modernization and the transition to green energy.